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a  b  s  t  r  a  c  t
Eight  manuscripts  have  speciﬁcally  examined  the  effects  of areca  (betel)  nut  use  in  preg-
nant women,  seven  of  which  have  documented  adverse  effects  on birth  weight,  newborn
neurological  status,  gender  ratio  and  pregnancy  outcomes  such  as  anaemia  and miscar-
riage  following  areca  nut use during  pregnancy.  A  retrospective  cohort  analysis  of  migrant
and refugee  pregnant  women  attending  antenatal  clinics  along  the Thai–Myanmar  border
(July 1997  to November  2006)  was  conducted  to examine  the  adverse  effects  of  areca  nut
use  routinely  recorded  on  enrolment.  Of 7685  women,  2284  (29.7%)  never  used  areca  or
smoked  (cheroots),  2484  (32.3%)  only  used  areca,  438  (5.7%)  only  smoked  cheroots  and
2479 (32.3%)  used  both  areca  and  cheroots.  Pieces  of  ripe  areca  nut  in  a leaf  with  lime,
without  tobacco,  were  used  particularly  among  older  multigravid  women.  Adverse  preg-
nancy  effects  were  not  observed  in  areca  nut  users  compared  with  non-users.  Smoking,  but
not  areca  nut  use,  had  a  dose-related  effect  on miscarriage.  Areca  nut  use  in  conjunction
with  smoking  reduced  the  adverse  effects  of smoking  on  birth  weight,  further  supporting  a
lack  of effect  of  areca  nut.  Areca  (betel)  nut-related  adverse  pregnancy  outcomes  were  not
observed  in  this  population,  whereas  smoking  was  clearly  harmful.  Differences  from  pre-
vious  reports  may  result  from  the amount  or types  of  areca  nut,  or quid  content,  consumed
between  countries.  Smoking,  but not  areca nut,  reduction  is  likely  to  improve  pregnancy
outcomes  on the  Thai–Myanmar  border.
opyrigCrown C
. Introduction
Areca (Areca catechu Linn.) nut is the fourth most com-
on  psychoactive substance in the world, with its usextending to 10–20% of the world’s population.1 The nut
tself contains alkaloids, including arecoline,2 which is
hought to be the main contributor to the nut’s stimulatory
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and toxic effects as described in human studies.3,4 Slaked
lime acts as a catalyst, enhancing the stimulatory effects
of the nut.5 Areca nut with slaked lime (calcium hydrox-
ide) wrapped in a Piper betel Linn. leaf (betel vine; family
Piperaceae) forms a quid. The contents of the quid are
important in terms of health effects as the contents vary
remarkably between individuals locally6 and between
countries7 and also depend upon the maturity of the
areca nut, with the ripe nut having a higher concentra-
tion of arecoline (0.12–0.24%) compared with the unripe
nut (0.11–0.14%).4,8–13 Spitting or swallowing of the quid
will also result in different effects on health. ‘Betel nut’ is
 behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved.
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botanically incorrect and confusing. This manuscript will
refer to areca nut, which is the seed of the fruit of the
oriental palm A. catechu Linn.8
Carcinoma and dental problems are a known con-
sequence of areca nut chewing,14,15 with animal data
suggesting that areca nut is teratogenic.16 In a review
of the literature, eight manuscripts speciﬁcally examined
the effects of areca nut use in a total of 1641 pregnant
women.4,9–13,17,18 Most manuscripts (5/7; 71%) reported
low birthweight (LBW)9,10,12,13,17 and 2 (25%) reported
reduced birth length.13,17 Three measured haemoglobin:
one reported a reduction in the frequency of maternal
anaemia with areca nut use11 and two found no signiﬁ-
cant effect.9,10 A higher maternal body mass index, reduced
weight gain during pregnancy and a reduced male newborn
rate were also found, but only in one paper.13 There were
variable reports on neonatal withdrawal.4,9 Arecoline was
detected in the placenta of mothers chewing areca nut in six
selected cases.4 No paper described a dose–response effect
on birth weight. Consumption of areca nut remains com-
mon  in the rural communities along the Thai–Myanmar
border.15 The aim of this study was to provide more infor-
mation on the effects of areca nut use in pregnancy and
to investigate the consequences of areca nut chewing in
refugee and migrant pregnant women and their newborns.
2. Methods
Mae  La refugee camp, 60 km north of Mae Sot in
Thailand, is the largest refugee camp for displaced peo-
ple, mostly of Karen ethnicity from Myanmar, along
the Thai–Myanmar border. Since 1986, Shoklo Malaria
Research Unit (SMRU) (Mae Sot, Thailand) has encouraged
women to attend antenatal clinics (ANC) for early detection
and treatment of malaria owing to a lack of effective pre-
ventative methods and where prevention is complicated
by multidrug-resistant Plasmodium falciparum.19 In 1998,
ANC care commenced for migrant women who live along
the border (but outside the camps). ANCs are open to all
women as soon as they are aware of their pregnancy. The
epidemiology of malaria and anaemia and their relation to
birth outcomes in this population are described in detail
elsewhere.19,20 The clinics are staffed by local health work-
ers. This study used the records of the ANCs of SMRU.
Smoking (not commercial cigarettes but cheroots) and
areca nut use in pregnancy were recorded at the ﬁrst ante-
natal visit. Women  who smoked daily or more than once
daily were classiﬁed as heavy smokers and those who  did
not smoke every day as light users. Women  who consumed
areca nut daily or more than once daily were classiﬁed as
heavy users and those who did not take areca nut every
day were light users. Women  smoke cheroots and most
commonly ‘Maw Htoo Wah’ (local Karen) or ‘Kye Lah’ (in
Burmese), a 15 cm length of white dried betel leaf wrap-
per ﬁlled with coarse ground tobacco and a ﬁlter made
from ‘Ahm way’, a blended herb that gives a sweet taste
to the smoke. The cheroots have previously been analysed
by the Laboratory of the Government Chemist (UK), reveal-
ing a high carbon monoxide yield (114 mg  per cheroot) and
a very high nicotine yield (3.8 mg  per cheroot).21 Women
were not routinely asked at enrolment about the use ofealth 4 (2012) 204– 209 205
alcohol or illicit drugs, as sale of alcohol is ofﬁcially for-
bidden in Mae  La refugee camp, alcohol abuse is rare and
illicit drug use is even more uncommon as punishment in
the past was severe.
The ﬁrst antenatal consultation includes an obstetric
and medical history and a detailed clinical examination
for all women. Recording of maternal height was not rou-
tine until 2006. A body mass index of <18 kg/m2 only in
women who attended in the ﬁrst trimester was used to
identify moderate or severe malnutrition. At each consul-
tation, women were provided with 1 week of thiamine
(vitamin B1, 100 mg  daily), as infantile beriberi was pre-
viously the main cause of infant mortality.22 Haematocrit
(Hct) samples were taken to screen for anaemia (Hct < 30%)
and, if present, anaemia treatment was  commenced, other-
wise prophylaxis with ferrous sulphate and folic acid were
provided. Hypertensive disorders were grouped together
and included pregnancy-induced hypertension, eclamp-
sia and pre-eclampsia, and chronic hypertension. Women
were encouraged to follow-up weekly and to deliver with
trained midwives in the SMRU delivery unit instead of
giving birth at home with a traditional birth attendant. Cae-
sarean section when needed was  at the nearest Thai public
hospital. All newborns were weighed using a Salter scale
accurate to 50 g (Salter, Birmingham, UK) and were exam-
ined by trained midwives, including those born at home.
Pregnancy records have been routinely entered into a data
recording system since 1987.
Ultrasound gestational age examination was estab-
lished at SMRU in August 2001.23 Prior to this, gestational
age was usually estimated by the Dubowitz gestational age
examination,24 fundal height formula25 or last menstrual
period if no other estimate was available. During July 1997
to July 2001, when the Dubowitz examination was  the main
predictor of gestation, it was routine for infants to have the
newborn neurological examination.26
This was  an historical cohort where all records of
women attending the ANC over a 9-year period (July 1997
to November 2006), the period where areca nut use was
detailed, were reviewed. Demographic and delivery data
were extracted, including ﬁrst and last weight, last Hct and
malaria infection. Ethical approval for review of the ante-
natal records was provided by the Oxford Tropical Research
Ethics Committee (reference: OXTREC 28-09).
A separate cohort of 513 pregnant women was  inter-
viewed in December 2010 as part of an audit of midwifery
advice provided to pregnant women. To provide coun-
selling on alcohol, smoking and areca nut use in pregnant
women, midwives conducted a cross-sectional survey to
detail how areca was  consumed in known users.
2.1. Pregnancy outcomes
Pregnancy outcomes were recorded on the ANC card
and were reported as live births (with or without con-
genital malformations), stillbirth, miscarriage or lost to
follow-up. Lost to follow-up was  deﬁned as discontinua-
tion of antenatal care before the outcome of pregnancy was
known, usually as a result of leaving the study area. Birth
weight and gender were also recorded. Birth weight analy-
sis was  conﬁned to live born, congenitally normal, singleton
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nfants weighed in the ﬁrst 72 h of life. LBW was deﬁned as
 weight below 2500 g, miscarriage as a pregnancy end-
ng before 28 weeks gestation, and stillbirth as a delivery
rom 28 weeks gestational age or ≥800 g birth weight in
hich the infant displays no sign of life (gasping, muscular
ctivity, cardiac activity); this was chosen as no ventilatory
upport is available in the clinics. Preterm births were those
elivered before 37 weeks gestation.
.2. Statistical analysis
Data were analysed in SPSS for Windows V.14.0 (SPSS,
enelux Inc., Gorinchem, The Netherlands). Continuous
ormally distributed data were described as the mean ± SD
nd non-normally distributed data as the median and
ange. To understand the effects of areca nut, women  were
rouped into ‘neither’ (those who never used areca or
moked), ‘areca only’, ‘smoke only’ or ‘areca and smoke’
those who used areca and smoked cheroots). Pairwise
omparisons against women who never used areca or
moked were made using Student’s t-test for normally
istributed data and the Mann–Whitney U-test for non-
ormally distributed data, and 2 or Fisher’s exact test for
omparison of proportions, only if the fourway comparison
as signiﬁcant after Bonferroni adjustment.
Associations of areca nut use with anaemia (vari-
bles included in the model were smoking, users of both,
ultigravida, trimester of ﬁrst ANC visit, anaemia at ﬁrst
NC consultation and malaria); and with LBW (variables
ncluded in the model were primigravida, trimester of ﬁrst
onsultation, malaria, gender of the newborn, smoking,
estational age at birth, mother’s weight at delivery) were
xamined. Covariates that were signiﬁcant at p < 0.10
ere included in a multivariate logistic regression model
able 1
haracteristics of 7685 pregnant women  attending antenatal care according to re
Population Neither
(n = 2284)
Areca only
(n = 2484)
Age (years) [mean ± SD (range)]b 24 ± 6 (14–46) 26 ± 6 (14–4
Teenager (age <20 years) [n (%)] 679 (29.7) 435 (17.5) 
Gravidity [median (range)] 2 (1–13) 3 (1–14) 
Parity  [median (range)]c 1 (0–10) 2 (0–11) 
Primigravida [n (%)] 832 (36.4) 536 (21.6) 
First  ANC visit gestational age [median
(range)]d
12 (–1 to 41) 11 (–2 to 42)
First  ANC visit in ﬁrst trimester [n (%)]e 1383/2277 (60.7) 1611/2483 (6
First  maternal weight in ﬁrst trimester
(kg) [mean ± SD (range)]
47 ± 7 (31–98) 48 ± 7 (31–8
Mean  maternal weight gain (kg)
[mean ± SD (IQR)]
7.5 ± 4.2 (5–10) 7.2 ± 4.1 (5–1
BMI  < 18 kg/m2 [n (%)]f 35/275 (12.7) 29/382 (7.6) 
Anaemic at ﬁrst antenatal visit (ﬁrst
trimester women only) [n (%)]
83/1374 (6.0) 99/1601 (6.2
Malaria  during pregnancy [n (%)] 411 (18.0) 341 (13.7) 
No.  of consultations [median (range)] 24 (1–41) 22 (1–41) 
NC: antenatal clinic; NS: not signiﬁcant; BMI: body mass index.
p-value: 1neither vs areca only; 2neither vs smokers; 3neither vs areca and smo
Age data not available for two women.
Parity refers to the number of deliveries of live born and stillborn; parity data no
First ANC gestational age not available for 17 women and <1.0 for gestational ag
First ANC visit in ﬁrst trimester not available for 13 women.
BMI  limited to a small number of women enrolled since 2006 and in ﬁrst trimes
 p < 0.001; ** p < 0.05.alth 4 (2012) 204– 209
where, using a stepwise approach, only those variables
that were signiﬁcant at p < 0.05 were retained in the ﬁnal
model and considered independent risk factors. Adjusted
odds ratios were given with their 95% CI.
3. Results
3.1. Study population
A total of 9264 pregnant women  were enrolled for ante-
natal care. There were 1289 women  (13.9%) who moved
from the study area before the outcome of their pregnancy
was  known and 290 (3.1%) had incomplete records for areca
nut use or smoking, leaving 7685 (83.0%) evaluable preg-
nancies. There were 4963 women  (64.6%) who reported
areca nut use in pregnancy. Areca nut users had differ-
ent characteristics than non-users (Table 1). Areca nut use,
smoking and use of both were more common in multi-
gravid women  and in women  of increasing age (p < 0.001
for both, linear trend; data not shown). Areca nut users
were more likely to attend for their ﬁrst consultation in
the ﬁrst trimester compared with non-users (Table 1).
Data on what women  smoked was available for 86.2%
of smokers (2514/2917) and, as previously reported,21 the
majority (1377/2514; 54.8%) smoked Maw  Htoo Wah.
3.2. Areca nut use
The proportion of women who used areca occasion-
ally, daily and more than once daily was  84.2% (n = 2092),
10.0% (n = 249) and 5.8% (n = 143), respectively, in areca
users alone, and 68.5% (n = 1697), 22.1% (n = 549) and
9.4% (n = 233), respectively, in users of both (p < 0.001,
linear trend). The proportion of heavy (daily or more
ported areca nut use and smoking in pregnancy
Smokers
(n = 438)
Areca and smoke
(n  = 2479)
p-valuea
8) 27 ± 7 (15–46) 29 ± 7 (15–48) 1–3 *
53 (12.1) 172 (6.9) 1–3 *
3 (1–12) 4 (1–16) 1–3 *
2 (0–10) 3 (0–13) 1–3 *
81 (18.5) 246 (9.9) 1–3 *
 12 (0 to 40) 11 (–1 to 41) 1 *, 2NS, 3 **
4.9) 262/438 (59.8) 1603/2474 (64.8) 1 **, 2NS, 3 **
8) 46 ± 6 (21–66) 46 ± 6 (30–82) 1–2 **, 3 *
0) 7.2 ± 3.7 (4–10) 7.0 ± 3.7 (5–9) 1–2NS, 3 **
5/28 (17.9) 23/227 (10.1) NS
) 20/262 (7.6) 134/1590 (8.4) 1–2NS, 3 **
120 (27.4) 496 (20.0) 1–3 *
19 (1–38) 22 (1–40) 1 *, 2 **, 3NS
ke.
t available for four women.
e due to inherent error in gestational measurements.
ter (n = 912).
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Table  2
Birth outcomes for women who use neither (areca or smoke cheroots) compared with areca only users, smokers and users of both
Population  Neither  Areca  only  Smokers  Areca  and  smoke  p-valuea
Miscarriage  [n  (%)] 176/2283b (7.7)  187/2484  (7.5)  60/438  (13.7)  326/2478b (13.2)  1NS,  2–3  *
High BP  in  pregnancy  [n  (%)]  53/2283  (2.3)  81/2484  (3.3)  11/438  (2.5)  70/2478  (2.8)  NS
Women who  delivered  (n)  2107  2297  378  2152
Stillborn [n  (%)]  21/2085  (1.0)  24/2285  (1.1)  3/372  (0.8)  36/2126  (1.7)  NS
Male offspring  [n  (%)]  1080/2083  (51.8)  1189/2285  (52.0)  192/376  (51.1)  1157/2116  (54.7)  NS
Congenital abnormalities  [n  (%)]  33/2092  (1.6)  34/2283  (1.5)  10/378  (2.6)  39/2131  (1.8)  NS
Live born,  normal  singletons  (n)  2009  2204  348  2015
Gestational age  at  birth  [median
(range)]
39.6  (28.3–45.4)  39.6  (30.0–45.0)  39.7  (30.9–42.6)  39.5  (28.6–44.2)  NS
Weighed in  72  h  (n) 1663  1951  275  1616
Mean ±  SD  birthweight  (g)
(range)
2940  ±  455  (900–4600)  2991  ±  460  (800–4900)  2828  ±  436  (1200–4100)  2891  ±  439  (1200–4270)  1  **,  2  *,  3  **
Proportion LBW  [n  (%)] 205/1663  (12.3) 203/1951  (10.4) 46/275  (16.7)  222/1616  (13.7)  NS
Median (range)  newborn
neurological  optimality  score
16  (6–20)  17  (4–20)  16  (12–20)  17  (8–20)  NS
Neonatal death  [n  (%)] 29/2064  (1.4) 31/2261  (1.4)  7/369  (1.9)  34/2090  (1.6)  NS
NS: not signiﬁcant (after Bonferroni adjustment); BP: blood pressure; LBW: low birthweight.
nd smo
.a p-value: 1neither vs areca only; 2neither vs smokers; 3neither vs areca a
b Maternal death before pregnancy outcome in one women in each group
*  p < 0.001; ** p < 0.05.
than once daily) areca nut use was signiﬁcantly higher
amongst women who also smoked (31.5%; 782/2479) com-
pared with non-smokers (15.8%; 392/2484) (p < 0.001).
There were 2284 women (29.7%) who never used areca or
smoked, 2484 (32.3%) who only used areca, 438 (5.7%) who
only smoked and 2479 (32.3%) who used areca and smoked
cheroots.
3.3. December 2010 audit
Midwives surveyed 513 pregnant women in December
2010 and self-reported alcohol use in the current preg-
nancy included 10.3% (n = 53) of antenatal care attendees.
Of these 53 women, 92.5% (n = 49) drank less than once a
week. Areca nut use was reported by 55.0% (282/513) of
women. Midwives reported that 86.2% of users (243/282)
consumed areca nut after meals, 66.0% (186/282) without
tobacco and 87.6% (247/282) in a P. betel Linn. leaf with
slaked lime. Most women used less than one whole nut
per day [53.9% (n = 152) compared with 31.6% (n = 89), 7.1%
(n = 20) and 7.4% (n = 21) who used one to four, ﬁve to nine
and ten or more whole nuts per day]. Tobacco use was more
likely in women who used more than one whole areca nut
per day compared with women who used less than one
nut per day [56.9% (74/130) vs 14.5% (22/152); p < 0.001].
The majority of users (80.9%; 228/282) added slaked lime,
spat initially and then swallowed the whole quid once
disintegrated.
3.4. Pregnancy outcomes
Two women died before the outcome of pregnancy
was known (severe malaria, ruptured uterus). There were
749 women (9.7%) who miscarried (Table 2). The higher
proportion of miscarriage amongst smokers and users of
both was dose related, with a higher frequency seen in
heavy (16.4%; 146/890) compared with occasional smokers
(11.9%; 241/2027; p = 0.001). In contrast, no dose–response
relationship was observed for miscarriage for heavyking.
(9.7%; 114/1174) compared with occasional areca nut users
(10.6%; 400/3789; p = 0.443).
Of the 6934 pregnancies where the outcome was deliv-
ery, there were 2.7% (n = 190) home births with missing
data for live birth (n = 66), gender (n = 74) and congenital
abnormalities (n = 50). The proportion of male infants, con-
genital abnormalities and stillbirths was  the same for areca
users, non-users, smokers and users of both (Table 2).
Gestational age was available for all of the 6576 live
born, normal, singletons and birth weight was available for
83.7% (5505) of the same infants, as some were weighed
after 72 h of birth. The mean difference in birth weight
between areca nut users and non-users was  51 g (95%
CI 21–80 g) (p = 0.001). Heavy smokers had babies with
a signiﬁcantly lower mean birthweight than those born
to occasional smokers [2851 ± 433 g (range 1200–4200 g)
vs 2896 ± 441 g (range 1200–4270 g); p = 0.037], but there
was no signiﬁcant difference in mean birthweight of babies
born to heavy areca users compared with occasional users
[2960 ± 458 g (range 1300–4380 g) vs 2940 ± 451 g (range
800–4900 g); p = 0.292].
Newborn neurological optimality score was  not sig-
niﬁcantly different between the groups (Table 2) and no
increase in hypotonia, tremor or startle response was
observed, which might be expected if babies suffered with-
drawal symptoms (data not shown).
Areca nut use was not associated with LBW on uni-
variate or multivariate analysis (Table 3) and was also not
associated with anaemia after adjustment for covariates
(Table 4).
4. Discussion
Areca nut use alone was not associated with any adverse
effects on maternal or neonatal outcomes in pregnant
Karen and Burmese women, in contrast to all,4,9,13,17,18except one,11 previous publications on the same subject.
As far as we  are aware, this is the largest cohort of areca
use recorded in pregnant women (n = 4963) in the pub-
lished literature. As reported previously in this population,
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Table 3
Risk factors associated with low birthweight (LBW)
Variable LBW (%) p-value
(univariate)
Adjusted OR (95% CI)
(n  = 6586)
Yes No
Areca nut user No 251/1938 (13.0) 1687/1938 (87.0) 0.264 Ref.
Yes 425/3567 (11.9) 3142/3567 (88.1) NS
Primigravida No 414/4222 (9.8) 3808/4222 (90.2) <0.001 Ref.
Yes 262/1283 (20.4) 1021/1283 (79.6) 2.26 (1.85–2.76)
First  ANC visit after trimester 1 No 397/3509 (11.3) 3112/3509 (88.7) 0.004 Ref.
Yes  279/1996 (14.0) 1717/1996 (86.0) 1.47 (1.21–1.78)
Malaria infection No 548/4660 (11.8) 4112/4660 (88.2) 0.002 Ref.
Yes 128/845 (15.1) 717/845 (84.9) NS
Smoker No 408/3614 (11.3) 3206/3614 (88.7) 0.002 Ref.
Yes  268/1891 (14.2) 1623/1891 (85.8) 1.54 (1.27–1.86)
Female infant No 322/2894 (11.1) 2572/2894 (88.9) 0.007 Ref.
Yes 352/2603 (13.5) 2251/2603 (86.5) 1.36 (1.14–1.64)
Mean  ± SD gestational age at birth (weeks) 37.8 ± 2.3 39.6 ± 1.2 <0.001 1.97 (1.85–2.09)
Mean  ± SD maternal weight at bookinga (kg) 45 ± 6 48 ± 7 <0.001 1.08 (1.06–1.10)
Ref.: reference group; NS: not signiﬁcant; ANC: antenatal clinic.
a Booking refers to the ﬁrst ANC visit to register the pregnancy.
Table 4
Risk factors associated with anaemia at delivery
Variable Anaemic at delivery (%) p-value
(univariate)
Adjusted OR (95% CI)
(n = 6881)
Yes No
Areca nut user No 425/2459 (17.3) 2034/2459 (82.7) 0.031 Ref.
Yes  858/4422 (19.4) 3564/4422 (80.6) NS
Smoker No 758/4370 (17.3) 3612/4370 (82.7) <0.001 Ref.
Yes  525/2511 (20.9) 1986/2511 (79.1) NS
Malaria infection No 979/5628 (17.4) 4649/5628 (82.6) <0.001 Ref.
Yes  304/1253 (24.3) 949/1253 (75.7) 1.47 (1.21–1.78)
Multigravida No 220/1563 (14.1) 1343/1563 (85.9) <0.001 Ref.
Yes 1063/5318 (20.0) 4255/5318 (80.0) 1.56 (1.33–1.84)
Anaemia at ﬁrst ANC visit No 857/5870 (14.6) 5013/5870 (85.4) <0.001 Ref.
Yes 426/1011 (42.1) 585/1011 (57.9) 4.13 (3.56–4.78)
R
s
n
p
a
u
n
h
n
u
t
b
c
p
d
P
p
r
p
h
r
c
fFirst ANC visit after trimester 1 No 694/4178 (16.6) 
Yes  589/2703 (21.8) 
ef.: reference group; NS: not signiﬁcant; ANC: antenatal clinic.
moking (cheroots) was a signiﬁcant risk factor for adverse
eonatal outcomes.21 Smoking and areca nut use in this
opulation did not result in worse outcomes than smoking
lone, lending support to the lack of adverse ﬁndings in
sers of areca only.
Certain adverse associations with areca nut use in preg-
ancy (LBW9,10,12,13,17 and reduced male births13) may
ave resulted from the small sample size and data selection
ot controlling for parity,13 malaria9–11 or other substance
se.12,13 However, the lack of signiﬁcant adverse associa-
ions of areca nut in this cohort of pregnant women  may
e due to differences in the way the nut is prepared and
onsumed across Asia. The majority of Karen and Burmese
regnant women consume a low number of ripe nuts per
ay, use P. betel Linn. leaf and do not add tobacco, whilst
apuans and Taiwanese use a higher number of unripe nuts
er day.5,8,11–13,27
Consistent with two of three prior publications, no
elationship with anaemia was apparent when other
otential causes were controlled for.9,10 Areca nut use
as been associated with reduced ovulation and increased
isk of miscarriage,28 however no increase in mis-
arriage was observed in this large cohort. This was
urther supported by ﬁnding a dose-dependent increase3484/4178 (83.4) <0.001 Ref.
2114/2703 (78.2) NS
in miscarriage with smoking but not with areca nut
use.
Data on neurological testing of newborns in resource-
poor settings is limited.26 In contrast to the hypotonia
in areca users reported by García-Algar et al.,4 there was
no increased rate of hypotonia in the cohort presented
here. Overall, we were unable to detect an effect of smok-
ing or areca on neurological optimality scores. This is not
unexpected as these women  continue to consume these
products post-partum.
These data were collected over a long period of time
(1997–2006), but the 2010 audit suggests the trend of
women  consuming areca nut during pregnancy continues.
It would have been useful to collect data on how each
woman  prepares and consumes her betel quid. This lack of
detail can be generalised to all the publications to date on
areca nut use in pregnancy. Further research on areca nut
use would beneﬁt from the inclusion of the type of areca
nut (ripe or unripe), estimated number of nuts per day, con-
tents of the quid including tobacco and use of the P. betel
leaf recently reported to have cancer preventive effects,29
and whether the woman  chews, spits or swallows.
Nevertheless, the daily consumption rate that was recorded
in the same way for areca and smoking in this cohort did
tional HA.L. Chue et al. / Interna
show dose–response relationships for adverse outcomes
with heavy smoking but not with heavy areca nut use. This
further supports the validity of a lack of adverse effects with
areca nut use in this population.
5. Conclusion
Although no harmful effects for the mother or neonate
following areca nut use during pregnancy were observed,
this does not negate the serious negative long-term effects
seen in chronic users. A public health initiative to reduce
smoking in pregnancy is of greater priority than one to
reduce areca nut consumption in this population.
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